Barcelona 2022

---

Acute respiratory distress syndrome: the path to precision medicine

Journal session
Chairs: L. Heunks (Amsterdam, Netherlands), R. Craven (London, United Kingdom), M. Barrecheguren Fernandez (Barcelona, Spain)
Aims: To present the most recent papers commissioned by The Lancet and The Lancet Respiratory Medicine, to provide insights into the pathophysiology and phenotypes of acute respiratory distress syndrome (ARDS), to review current approaches for diagnosis and management of paediatric and adult patients, to consider therapeutic options in development for this heterogeneous syndrome, to discuss the needs of patients with long-term sequelae of ARDS and to set out future directions for research and clinical practice. This forward-looking session will provide new insights into mechanisms and management for both nonspecialists and specialists, with a focus on the goal of precision medicine.

Causes, pathophysiology, and phenotypes of acute respiratory distress syndrome L. Ware (Nashville, United States)
Acute respiratory distress syndrome in adults: diagnosis, management, outcomes and long-term sequelae D. Mcauley (Belfast (Belfast), United Kingdom)
Paediatric acute respiratory distress syndrome: developing management strategies to improve outcomes M. Kneyber (Groningen, Netherlands)
Opportunities for improved clinical trial designs in acute respiratory distress syndrome M. Matthay (San Francisco, United States)
Discussion and Q&A